Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population

Cancer Research

Volumn 64, Issue 3, 2004, Pages 920-927

  Brat, Daniel J ^a,c   Castellano Sanchez, Amilcar A ^a   Hunter, Stephen B ^a   Pecot, Marcia ^a   Cohen, Cynthia ^a   Hammond, Elizabeth H ^b   Devi, Sarojini N ^a   Kaur, Balveen ^a   Van Meir, Erwin G ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LDS HOSPITAL   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; GELATINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SCLEROPROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CELL DENSITY; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; INFLAMMATORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPALISADE CELL; THROMBOSIS; TUMOR CELL; TUMOR NECROSIS; VASOCONSTRICTION;

APOPTOSIS; ASTROCYTOMA; CELL COUNT; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NECROSIS; RECEPTORS, CELL SURFACE; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0842325802     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2073     Document Type: Article

References (40)

1. Kleihues, P., Burger, P. C., Collins, V. P., Newcomb, E. W., Ohgaki, H., and Cavenee, W. K. Glioblastoma. In: P. Kleihues and W. K. Cavenee, (eds). Pathology and Genetics of Tumours of the Nervous System, 2nd ed., pp. 29-39. Lyon: International Agency for Research on Cancer, 2000.
2. Brat, D. J., Castellano-Sanchez, A., Kaur, B., and Van Meir, E. G. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv. Anat. Pathol., 9: 24-36, 2002.
3. Barker, F. G., 2nd, Davis, R. L., Chang, S. M., and Prados, M. D. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer (Phila.), 77: 1161-1166, 1996.
4. Burger, P. C., and Vollmer, R. T. Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer (Phila.), 46: 1179-1186, 1980.
5. Brat, D. J., Kaur, B., and Van Meir, E. G. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Front. Biosci., 8: D100-116, 2003.
6. Brat, D. J., and Van Meir, E. G. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am. J. Pathol., 158: 789-796, 2001.
7. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
8. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1999.
9. Zagzag, D., Amirnovin, R., Greco, M. A., Yee, H., Holash, J., Wiegand, S. J., Zabski, S., Yancopoulos, G. D., and Grumet, M. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab. Invest., 80: 837-849, 2000.
10. Straume, O., Chappuis, P. O., Salvesen, H. B., Halvorsen, O. J., Haukaas, S. A., Goffin, J. R., Begin, L. R., Foulkes, W. D., and Akslen, L. A. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res., 62: 6808-6811, 2002.
11. Chan, P. T. H., and Weller, R. O. Factors influencing tumor cell and vascular proliferation in glioblastoma. Neuropathol. Appl. Neurobiol., 28: 155-156, 2002.
12. Onda, K., Davis, R. L., Wilson, C. B., and Hoshino, T. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol. (Berl)., 87: 586-593, 1994.
13. Tachibana, O., Lampe, J., Kleihues, P., and Ohgaki, H. Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathol. (Berl)., 92: 431-434, 1996.
14. Takekawa, Y., Sawada, T., and Sakurai, I. Expression of apoptosis and its related protein in astrocytic tumors. Brain Tumor Pathol., 16: 11-16, 1999.
15. Gown, A. M., and Willingham, M. C. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J. Histochem. Cytochem., 50: 449-554, 2002.
16. Kaur, B., Brat, D. J., Calkins, C. C., and Van Meir, E. G. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. Am. J. Pathol., 162: 19-27, 2003.
17. Giannini, C., Scheithauer, B. W., Burger, P. C., Christensen, M. R., Wollan, P. C., Sebo, T. J., Forsyth, P. A., and Hayostek, C. J. Cellular proliferation in pilocytic and diffuse astrocytomas. J. Neuropathol, Exp. Neurol., 58: 46-53, 1999.
18. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
19. Damert, A., Machein, M., Breier, G., Fujita, M. Q., Hanahan, D., Risau, W., and Plate, K. H. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res., 57: 3860-3864, 1997.
20. Sondergaard, K. L., Hilton, D. A., Penney, M., Ollerenshaw, M., and Demaine, A. G. Expression of hypoxia-inducible factor 1α in tumours of patients with glioblastoma. Neuropathol. Appl. Neurobiol., 28: 210-217, 2002.
21. Vordermark, D., and Brown, J. M. Evaluation of hypoxia-inducible factor-1α (HIF-1á) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. Int. J. Radiat. Oncol. Biol. Phys., 56: 184-1193, 2003.
22. Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., and Semenza, G. L. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer (Phila.), 88: 2606-2618, 2000.
23. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., and Semenza, G. L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res., 63: 1138-1143, 2003.
24. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., and Comoglio, P. M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3: 347-361, 2003.
25. Zagzag, D., Nomura, M., Friedlander, D. R., Blanco, C. Y., Gagner, J. P., Nomura, N., and Newcomb, E. W. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1α) in glioma cell invasion. J. Cell Physiol., 196: 394-402, 2003.
26. Ben-Yosef, Y., Lahat, N., Shapiro, S., Bitterman, H., and Miller, A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res., 90: 784-791, 2002.
27. Graham, C. H., Forsdike, J., Fitzgerald, C. J., and Macdonald-Goodfellow, S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer. 80: 617-623, 1999.
28. VanMeter, T. E., Rooprai, H. K., Kibble, M. M., Fillmore, H. L., Broaddus, W. C., and Pilkington, G. J. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neuro-Oncol., 53: 213-235, 2001.
29. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L., and Rao, J. S. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56: 384-392, 1996.
30. Uhm, J. H., Dooley, N. P., Villemure, J. G., and Yong, V. W. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis, 14: 421-433, 1996.
31. Tonn, J. C., Kerkau, S., Hanke, A., Bouterfa, H., Mueller, J. G., Wagner, S., Vince, G. H., and Roosen, K. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int. J. Cancer, 80: 764-772, 1999.
32. Raithatha, S. A., Muzik, H., Muzik, H., Rewcastle, N. B., Johnston, R. N., Edwards, D. R., and Forsyth, P. A. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro-Oncol., 2: 145-150, 2000.
33. de Vries, T. J., Quax, P. H., Denijn, M., Verrijp, K. N., Verheijen, J. H., Verspaget, H. W., Weidle, U. H., Ruiter, D. J., and van Muijen, G. N. Plasminogen activators, their inhibitors, and urokinase receptor emerge in fate stages of melanocytic tumor progression. Am. J. Pathol., 144: 70-81, 1994.
34. Blasi, F., and Carmeliet, P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell. Biol., 3: 932-943, 2002.
35. Mori, T., Abe, T., Wakabayashi, Y., Hikawa, T., Matsuo, K., Yamada, Y., Kuwano, M., and Hori, S. Up-regulation of urokinase type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-α or basic fibroblast growth factor. J. Neuro-Oncol., 46: 115-123, 2000.
36. Mohanam, S., Sawaya, R., McCutcheon, I., Ali-Osman, F., Boyd, D., and Rao, J. S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res., 53: 4143-4147, 1993.
37. Raza, S. M., Lang, F. F., Aggarwal, B. B., Fuller, G. N., Wildrick, D. M., and Sawaya, R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery, 51: 2-12, 2002.
38. Rodas, R. A., Fenstermaker, R. A., McKeever, P. E., Blaivas, M., Dickinson, L. D., Papadopoulos, S. M., Hoff, J. T., Hopkins, L. N., Duffy-Fronckowiak, M., and Greenberg, H. S. Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report. J. Neurosurg., 89: 200-205, 1998.
39. Walsh, D. C., and Kakkar, A. K. Thromboembolism in brain tumors. Curr. Opin. Pulm. Med., 7: 326-331, 2001.
40. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., and Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (Wash. DC), 284: 1994-1998, 1999.